Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
Acta Clin Croat ; 60(3): 519-524, 2022 Feb.
Article in English | MEDLINE | ID: mdl-35282497

ABSTRACT

The management of bladder cancer patients largely depends on pathologic staging and grading, and current morphological classification does not always show the individual patient's risk. Despite modern surgical techniques, pre- and postoperative therapies, clinical outcomes of these patients have not changed over decades. Today, there are new biomarkers for bladder cancer showing changes in tumor biology and progression, as a result of changes in the pathways affecting cell signaling, proliferation, apoptosis, epigenetic changes, angiogenesis, and modulation of host immune response. Assessment of multiple biomarkers associated with those pathways offers new understanding of tumor behavior while identifying important panels of predicting patient management and outcomes. In this review, the most important molecules and basics of the novel molecular classification of bladder cancer are presented.


Subject(s)
Urinary Bladder Neoplasms , Biomarkers , Epigenesis, Genetic , Humans , Neovascularization, Pathologic , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology
2.
Anticancer Res ; 40(4): 2323-2329, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32234933

ABSTRACT

BACKGROUND/AIM: The aim of this study was to determine the association between total triiodothyronine (T3), free fraction of thyroxin (FT4), and thyrotropin (TSH) levels with prostate cancer histopathological features. PATIENTS AND METHODS: Blood samples from 140 patients with prostate cancer were analyzed preoperatively and stratified according to postoperative histopathological differentiation. The first group (N=62) included patients with prostate cancer Grade Groups (GG) 1-2, while the second group (N=63) included patients with prostate cancer GG 3-5. RESULTS: T3 levels were significantly higher in patients with prostate cancer GG 3-5 (p=0.047). There was no significant difference in the FT4 and TSH levels between the two groups (p=0.680 and 0.801, respectively). T3 levels were positively correlated with tumor percentage involvement (TPI) (p=0.002), and pT stage (p=0.047) on definitive pathology. CONCLUSION: Higher T3 levels are associated with several indicators of prostate cancer histopathological aggressiveness.


Subject(s)
Prostatic Neoplasms/surgery , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Aged , Humans , Male , Middle Aged , Neoplasm Grading , Neoplasm Staging , Preoperative Period , Prospective Studies , Prostate-Specific Antigen/blood , Prostatectomy/methods , Prostatic Neoplasms/blood , Prostatic Neoplasms/pathology
3.
Acta Clin Croat ; 58(1): 180-182, 2019 Mar.
Article in English | MEDLINE | ID: mdl-31363341

ABSTRACT

Primary malignant melanoma of the urinary bladder is rare, with only 20 cases reported to date. We present a case of an 87-year-old woman with multiple comorbidities who presented with advanced urinary bladder neoplasm. Histopathologic analysis suggested melanoma of the urinary bladder. No previous or concurrent diagnosis of cutaneous melanoma was documented. The patient underwent transurethral resection of the tumor before and during hospitalization at our hospital but died shortly after due to widespread disease. Autopsy was not performed.


Subject(s)
Melanoma/pathology , Urinary Bladder Neoplasms/pathology , Aged, 80 and over , Female , Humans , Melanoma/surgery , Treatment Failure , Urinary Bladder/pathology , Urinary Bladder Neoplasms/surgery
4.
Acta Clin Croat ; 57(Suppl 1): 9-20, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30457242

ABSTRACT

The history of Croatian urology clearly shows its affiliation to the medical and civilizational circle of the Western world. The Department of Urology at the Sestre milosrdnice University Hospital Center is the oldest urology institution in the Republic of Croatia. The Department was established in 1894, when the new Sestre milosrdnice Hospital was open in Vinogradska cesta in Zagreb. It was then that doctor Dragutin Masek founded the so-called III Department, which, in addition to treating urology patients, also treated patients with conditions of the ear, nose and throat, eye diseases and dermatologic conditions. Dragutin Masek had already realized that medicine would soon be divided into fields and had assigned younger doctors joining the III Department to specific fields. As a result, urology was given to Aleksandar Blaskovic, who founded the first independent department of urology in Croatia in 1926. In 1927, he was appointed Professor of urology at the Zagreb School of Medicine, where he established the first department of urology and was giving lectures and practicals. Under his leadership, the Department of Urology was given the status of a Clinic, a teach-ing department, the first of its kind in Croatia. Owing to all his activities in the field of urology, the history remembers him as the "father of modern Croatian urology". Over the course of the following years, department chairs had changed, but luckily for the patients, approach to work had not. Conscientiousness, trust, competence and charity. After all, charity is the idea that the hospital carries even in its name, after the Sisters of Charity who had founded it. In all the decades, the Department of Urology has been following global development paths, objectively legging behind top facilities in the world by only a few years. Overall professional and scientific urology activities culminated in 1998, when the Clinic became the Reference Center of the Ministry of Health of the Republic of Croatia for prostate cancer, and in 2011, when it became the European Board of Urology Certified Center. All that has been achieved could not have been done without wholehearted help and cooperation of the nurses, as well as every other department employee from the beginnings of urology until today. Despite its rich history, the Department does not rest on laurels. Today, it is a modern urology department together with its European role models.


Subject(s)
Hospitals, University , Urology , Croatia , History, 20th Century , Humans , Leadership , Skin Diseases , Urology/history
5.
Acta Clin Croat ; 57(Suppl 1): 77-84, 2018 Jun.
Article in English | MEDLINE | ID: mdl-30457253

ABSTRACT

Stress urinary incontinence (SUI) continues to present a major complication after radical prostatectomy. Suburethral slings represent one of the less invasive options for postprostatectomy SUI, and a more recent addition is a transobturator sling, the AdVance®. We report our results with the AdVance® sling for the management of postoperative SUI. The evaluation was conducted on 47 patients with AdVance® implant for SUI in our institution (November 2010 - June 2017). Measurements included age, etiology of SUI, duration of SUI, follow-up and pad use per day (PPD) pre- and postoperatively. Patients were classified as cured if they used no pads or 1 PPD for security reasons, or as improved if 1-2 PPDs were used and if there was a 50% reduction in pad use per day postoperatively. In our series we observed a reduction of mean PPD of 5.1 (2-8) to 1.7 (0-4) postoperatively. After follow-up and according to our criteria, the cure rate was 51.1% (24/47) and the improvement rate 27.5% (13/47). The overall success rate was 78.6% (37/47). No improvement was observed in 21.4% (10/47) of patients. Failure rates after sling placement for patients with addi-tional treatments following prostatectomy were much higher (60% (3/10) for radiation therapy and 66.7% (4/10) for urethral stricture disease). Our results show favourable cure and improvement rates and are comparable to results from larger series. The most appropriate candidates for the AdVance® sling are patients with mild to moderate postprostatectomy SUI. The results may be even better in patients without additional treatment following prostatectomy, such as radiation therapy or surgery for stricture disease.


Subject(s)
Prostatectomy , Suburethral Slings , Urinary Incontinence, Stress , Humans , Male , Prostatectomy/adverse effects , Treatment Outcome , Urinary Incontinence, Stress/etiology , Urinary Incontinence, Stress/surgery
6.
Acta Clin Croat ; 57(Suppl 1): 85-88, 2018 Oct.
Article in English | MEDLINE | ID: mdl-30457254

ABSTRACT

Prostate adenocarcinoma with Paneth cell-like neuroendocrine differentiation is a rare entity. Foci of scattered cells and small clusters are found in the majority of described cases, although cases with predominant Paneth cell-like features have also been recorded. These cells contain eosinophilic cytoplasmic inclusions and lack androgen receptors, and are consequently immune to hormone therapy. It is, therefore, important for pathologists to recognize them. According to literature, clinical outcome depends on the standard grading of the conventional prostate cancer component. We report a case of a 54 year-old patient with prostatic adenocarcinoma showing Paneth cell-like neuroendocrine differentiation.


Subject(s)
Adenocarcinoma , Paneth Cells , Prostatic Neoplasms , Adenocarcinoma/pathology , Humans , Male , Middle Aged , Prostatic Neoplasms/pathology
7.
Acta Clin Croat ; 54(3): 363-6, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26666109

ABSTRACT

The aim is to report a rare case of squamous cell carcinoma arising in a urinary bladder diverticulum and present recent literature overview of treatment options. A 56-year-old man presented with intermittent hematuria. Ultrasound examination indicated primary carcinoma in the urinary bladder diverticulum. Diagnosis was confirmed with cystoscopy and computed tomography. Transvesical diverticulectomy with regional lymphadenectomy was undertaken. Two years after initial treatment, the patient was well without evidence of tumor relapse. This report implicates that although aggressive surgical approach is recommended in the majority of bladder diverticulum tumors, simple diverticulectomy may be indicated in selected, confined cases.


Subject(s)
Carcinoma, Squamous Cell/surgery , Carcinoma, Transitional Cell/surgery , Diverticulum/pathology , Urinary Bladder/abnormalities , Carcinoma, Squamous Cell/diagnostic imaging , Carcinoma, Squamous Cell/pathology , Carcinoma, Transitional Cell/diagnostic imaging , Carcinoma, Transitional Cell/pathology , Diverticulum/diagnostic imaging , Humans , Male , Middle Aged , Organ Sparing Treatments , Tomography, X-Ray Computed , Treatment Outcome , Urinary Bladder/diagnostic imaging , Urinary Bladder/pathology
8.
Cesk Patol ; 51(1): 50-2, 2015.
Article in English | MEDLINE | ID: mdl-25671363

ABSTRACT

UNLABELLED: Synchronous occurrence of benign and malignant kidney tumours is very rare. We present the case of a 63-year-old female patient who underwent a bilateral partial nephrectomy after being diagnosed with bilateral kidney tumours by ultrasonography and a computed tomography scan. Histopathological analysis of the left kidney tumour mass revealed a chromophobe renal cell carcinoma. In the right kidney specimen clear cell renal cell carcinoma was found along with a small angiomyolipoma and renomedullary interstitial cell tumour. There were no indications for subsequent chemotherapy. At present, three years after the surgery, the patient has had no signs of relapse and maintains normal renal function. KEYWORDS: bilateral kidney tumours - renal cell carcinoma - angiomyolipoma.


Subject(s)
Angiomyolipoma/pathology , Carcinoma, Renal Cell/pathology , Kidney Neoplasms/pathology , Neoplasms, Multiple Primary/pathology , Angiomyolipoma/surgery , Carcinoma, Renal Cell/surgery , Female , Humans , Kidney Neoplasms/surgery , Middle Aged , Neoplasms, Multiple Primary/surgery , Nephrectomy
9.
Coll Antropol ; 38(2): 763-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-25145020

ABSTRACT

Herein we present 82-year-old man with leiomyosarcoma arising from the spermatic cord with scalp metastasis, five years after primary surgical treatment. Complete surgical excision is required in such cases, as well as precise evaluation of further therapy. Paratesticular leiomyosarcoma is a rare entity, malignant mesenchimal tumor of smooth muscle differentiation. Although leiomyosarcomas of different localizations have well-known metastatic potential, cutaneous metastases are extremely rare with only 16 cases described in the literature. To our knowledge there are no reported cases of the paratesticular leiomyosarcoma metastatic to the skin. This article reviews the literature regarding paratesticular leiomyosarcoma presentation, diagnosis and treatment.


Subject(s)
Leiomyosarcoma/diagnosis , Skin Neoplasms/secondary , Spermatic Cord/pathology , Aged , Aged, 80 and over , Humans , Leiomyosarcoma/pathology , Leiomyosarcoma/surgery , Male , Scalp/pathology
10.
Acta Clin Croat ; 49(4): 453-7, 2010 Dec.
Article in English | MEDLINE | ID: mdl-21830457

ABSTRACT

A 65-year-old man was referred to our department with clinical signs of septic shock and necrotizing soft tissue infection of the scrotal, perianal and right inguinal region. Initial presentation was a typical Fournier's gangrene. Because of the life-threatening condition, the initial treatment was extensive removal of necrotic tissue. Antibiotic therapy was administered and several debridements of the wound were done afterwards. Three weeks after the initial treatment, wide wound defects of the perianal, scrotal and inguinal regions were closed secondarily and the patient was discharged from the hospital. Fournier's gangrene is a surgical emergency. Although rare, it remains a life-threatening disease. Rapid and accurate diagnosis remains the key component in achieving successful outcome. Early aggressive surgical intervention together with fluid, hemodynamic and nutritional support and broad-spectrum antibiotics is the essential management to reduce mortality.


Subject(s)
Fournier Gangrene/surgery , Aged , Debridement , Fournier Gangrene/pathology , Humans , Male , Necrosis , Perineum , Scrotum
SELECTION OF CITATIONS
SEARCH DETAIL
...